![Atai Life Sciences N.V. logo](/logos/ATAI.webp)
Atai Life Sciences N.V.
NASDAQ:ATAI
Overview | Financials
Company Name | Atai Life Sciences N.V. |
Symbol | ATAI |
Currency | USD |
Price | 1.19 |
Market Cap | 199,680,810 |
Dividend Yield | 0% |
52-week-range | 1.025 - 2.85 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Florian Brand |
Website | https://www.atai.life |
An error occurred while fetching data.
About Atai Life Sciences N.V.
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD